Chronic Airway Diseases – A travel in time

Chronic airway diseases such as asthma and COPD represent a major global healthcare burden affecting individuals of all ages. The demographic trends worldwide signal the growing problem of chronic respiratory care in an ageing population.

There is a growing consensus that we need to focus on prevention, earlier detection of risk populations and on earlier interventions for chronic airway diseases.

The more recent development of targeted therapies and biologics have advanced the field clinically and also shed some light on the nature of airway inflammation, thereby challenging our classical categorization of airway diseases. The expected advent of RNA-based therapies is likely to challenge our thinking about chronic disease even further. 

Frequent diseases such as asthma, bronchitis and COPD will likely benefit from digital tools and AI for the diagnosis and probably more importantly also for the care of the huge numbers of patients with chronic airway disease. 

Join us for an exciting symposium wthat will not only allow you to travel in time from childhood to adulthood but will reflect the huge changes in our understanding of the risk factors, including early life events, for chronic obstructive lung diseases and their associated multimorbidity.

We will also address treatment concepts that have truly undergone significant changes in respiratory medicine and after an era of small mocelues, we are now facing the benefits of antibodies and biologics allowing for a personalised approach of chronic diseases and we are already awaiting the next generation of drugs that are RNA - based therapies.

Klaus F. Rabe